LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 17.28 | 27.76 | 875 | 838 | 1.0433 | 1.0173 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 17.28 | 27.76 | 1047 | 838 | 1.2483 | 1.0923 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 18.98 | 27.76 | 249 | 941 | 0.2646 | 0.5397 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 18.98 | 27.76 | 997 | 941 | 1.0594 | 1.0228 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 18.98 | 27.76 | 908 | 941 | 0.9648 | 0.9859 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 18.98 | 27.76 | 1043 | 941 | 1.1082 | 1.0408 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 20.68 | 27.76 | 490 | 1119 | 0.4379 | 0.7131 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 20.68 | 27.76 | 1010 | 1119 | 0.9026 | 0.9619 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 20.68 | 27.76 | 970 | 1119 | 0.8669 | 0.9471 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 20.68 | 27.76 | 1057 | 1119 | 0.9446 | 0.9787 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 22.39 | 27.76 | 723 | 1305 | 0.5537 | 0.7981 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 22.39 | 27.76 | 1033 | 1305 | 0.7911 | 0.9174 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 22.39 | 27.76 | 967 | 1305 | 0.7406 | 0.8948 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 22.39 | 27.76 | 1037 | 1305 | 0.7942 | 0.9188 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 24.09 | 27.76 | 795 | 1461 | 0.5439 | 0.7980 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 24.09 | 27.76 | 1033 | 1461 | 0.7067 | 0.8822 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 24.09 | 27.76 | 992 | 1461 | 0.6787 | 0.8689 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 24.09 | 27.76 | 1043 | 1461 | 0.7136 | 0.8854 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 25.79 | 27.76 | 879 | 1605 | 0.5476 | 0.8045 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 25.79 | 27.76 | 1034 | 1605 | 0.6442 | 0.8553 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 25.79 | 27.76 | 1007 | 1605 | 0.6274 | 0.8469 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 25.79 | 27.76 | 1047 | 1605 | 0.6523 | 0.8592 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 27.49 | 27.76 | 890 | 1723 | 0.5165 | 0.7900 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 27.49 | 27.76 | 1023 | 1723 | 0.5937 | 0.8324 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 27.49 | 27.76 | 1025 | 1723 | 0.5948 | 0.8330 | MN20160318_Q01 | I08 |